Updated: Illumina's $7.1B Grail deal being investigated by SEC
The US Securities and Exchange Commission is probing Illumina’s $7.1 billion buyout of Grail, Illumina disclosed in a regulatory filing Thursday afternoon.
The DNA sequencing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.